REGENXBIO Inc.RGNXNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank17
3Y CAGR-13.1%
5Y CAGR-9.2%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-13.1%/yr
vs +6.6%/yr prior
5Y CAGR
-9.2%/yr
Recent deceleration
Acceleration
-19.7pp
Decelerating
Percentile
P17
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.68 | +16.3% |
| 2024 | 4.89 | -47.5% |
| 2023 | 9.31 | +7.4% |
| 2022 | 8.66 | +260.8% |
| 2021 | 2.40 | -74.0% |
| 2020 | 9.22 | -77.5% |
| 2019 | 41.01 | +511.3% |
| 2018 | 6.71 | -92.6% |
| 2017 | 91.06 | -10.1% |
| 2016 | 101.34 | - |